Business

Elon Musk's $97.4 billion offer to buy OpenAI, the nonprofit that runs ChatGPT, was rejected by CEO Sam Altman. Altman countered with an offer to buy Twitter for $9.74 billion.

Published on: February 10, 2025, 11:01 PM UTC

The Trump administration's dismantling of the Consumer Financial Protection Bureau leaves consumers vulnerable to unfair treatment by financial institutions. The agency enforced laws protecting consumers from predatory lending, inaccurate credit billing, and discrimination. Its elimination means no one is policing the nation's largest financial firms. States have varying consumer protection laws, but enforcement is inconsistent. The lack of oversight creates uncertainty for businesses and puts low-income consumers at greater risk.

Published on: February 10, 2025, 11:01 PM UTC

Coca-Cola (KO) Q4 Earnings Preview: Sales Growth Driven by Price Increase, Margin Pressure from FX Headwinds

Published on: February 10, 2025, 11:00 PM UTC

Southwest Airlines names Tom Doxey as new CFO, replacing retiring Tammy Romo.

Published on: February 10, 2025, 11:00 PM UTC

Mexican billionaire Carlos Slim reevaluates Pemex deal for Mexico's deepwater gas field, despite viability issues and low gas prices.

Published on: February 10, 2025, 11:00 PM UTC

Vertex Pharmaceuticals forecasts strong revenue growth driven by cystic fibrosis drug sales and contributions from newly approved non-opioid painkiller; aims to launch five new treatments by 2028.

Published on: February 10, 2025, 10:10 PM UTC

Columbus McKinnon (CMCO) missed Q4 estimates with a 7.9% revenue decline year-on-year. Non-GAAP EPS fell 23.3% short of expectations. Despite long-term revenue growth of 3.3%, analysts project a 6.7% increase in the next 12 months. While the operating margin has been consistent at 8.8%, it dropped to 7.6% in Q4. EPS has declined by 3.9% annually over the last five years, with a two-year decline of 5.2%.

Published on: February 10, 2025, 10:10 PM UTC

Coty Inc. (COTY) reported second-quarter earnings of $23.7 million, missing Wall Street expectations. Adjusted EPS was 11 cents per share, below the 22-cent estimate, while revenue of $1.67 billion also fell short of forecasts.

Published on: February 10, 2025, 10:09 PM UTC

Vertex Pharmaceuticals (VRTX) Q4 results beat revenue estimates, rising 15.7% YoY to $2.91B. Non-GAAP EPS of $3.98 missed by 1%. Full-year revenue guidance at $11.88B aligns with estimates, implying 7.8% growth. Read our analysis to determine if now is the time to buy VRTX.

Published on: February 10, 2025, 10:09 PM UTC

Radiant Logistics Inc. (RLGT) Reports Fiscal Q2 Profit of $6.5 Million

Published on: February 10, 2025, 10:09 PM UTC